A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors
Clinical trial NCT03099109 · COMPLETED
Trial details
- NCT number
- NCT03099109
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-12
- Primary completion
- 2019-12-10
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.